image
Adaptimmune Therapeutics plc ADAP
Healthcare - Biotechnology - NASDAQ - GB
Watchlist
$ 0.2564
-0.659 %
$ 65.6 M
Market Cap
-0.85
P/E
BALANCE SHEET
246 M ASSETS
-12.97%
Growth Rates
1Year -12.97%
3Years -19.39%
5Years 6.26%
7Years -1.89%
10Years 16.05%
234 M LIABILITIES
-3.70%
Growth Rates
1Year -3.70%
3Years -3.88%
5Years 32.23%
7Years 16.97%
10Years 15.99%
11.8 M EQUITY
-70.01%
Growth Rates
1Year -70.01%
3Years -61.40%
5Years -37.44%
7Years -33.36%
10Years 17.26%
BALANCE SHEET DECOMPOSITION
Balance Sheet Adaptimmune Therapeutics plc
image
Current Assets 188 M
Cash & Short-Term Investments 152 M
Receivables 1.45 M
Other Current Assets 35.1 M
Non-Current Assets 57.8 M
Long-Term Investments 0
PP&E 51.2 M
Other Non-Current Assets 6.58 M
61.64 %14.27 %20.82 %Total Assets$246.0m
Current Liabilities 64.5 M
Accounts Payable 8.69 M
Short-Term Debt 4.71 M
Other Current Liabilities 51.1 M
Non-Current Liabilities 170 M
Long-Term Debt 19.3 M
Other Non-Current Liabilities 150 M
3.71 %21.84 %8.23 %64.21 %Total Liabilities$234.1m

Balance Sheet

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Jun-2015 Jun-2014 Jun-2013 Jun-2012
ASSETS
Cash & Cash Equivalents 91.1 144.0 108.0 149.9 56.9 50.4 68.4 84.0 158.8 229.1 51.3 0.2 3.0
Short Term Investments 60.5 2.9 96.6 219.6 311.3 39.1 136.8 124.2 22.7 55.3 0 0 0
Receivables 1.5 46.9 7.4 0.8 0.1 19.3 0.2 0.2 1.5 5.4 4 K 27.4 K 0.7
Inventory 7.3 0 1.3 0.7 2.1 1.5 1.1 3.8 1.2 0.1 1 2 0.128
Other Current Assets 27.8 13.7 51.5 54.2 34.0 10.2 32.0 24.1 22.0 5.2 10.6 1.4 0.6
Total Current Assets 188.2 207.6 255.4 415.5 398.2 120.5 231.1 230.2 198.8 295.1 54.1 1.6 3.9
PP&E 51.2 71.7 71.5 51.4 46.7 51.9 36.1 40.7 27.9 5.4 1.4 0.2 97.4 K
Intangible Assets 3.9 0.3 0.4 1.0 1.7 2.2 1.5 1.3 1.3 0.2 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 1.6 1.7 4.6 4.5 4.1 4.3 4.0 4.5 0 0 0
Other Long Term Assets 2.7 3.0 1.6 1.7 4.6 7.0 8.1 8.9 6.6 4.7 0 0 0
Other Assets 0 0 0 0 0 0 0 0 0 0 1 1 0
Total Assets 246.0 282.6 328.9 469.5 451.1 181.5 276.7 281.1 234.5 300.7 55.5 1.8 4.0
LIABILITIES
Accounts Payable 8.7 8.1 4.8 8.1 6.4 6.4 4.1 8.4 11.3 2.0 2.0 1.0 1.9
Short Term Debt 4.7 5.4 5.5 4.6 5.5 5.0 0 0 0 1 0 41.6 1.5
Other Current Liabilities 38.8 28.9 30.8 27.6 24.3 20.9 20.4 21.5 15.5 3.6 (4.6) 50.5 0.7
Total Current Liabilities 64.5 72.8 64.5 62.5 39.1 34.3 24.4 74.3 40.3 26.8 53.1 4.0 4.1
Long Term Debt 19.3 19.9 40.7 46.3 41.9 45.9 0 0 0 0 0 0 0
Deferred Tax Income 0 0 0 0 0 0 1.4 2.2 0 0 0 0 0
Other Liabilities 150.3 1.4 (19.1) (22.5) (20.3) (22.4) 5.4 3.8 3.1 (12.2) 0 0 0
Total Liabilities 234.1 243.1 247.0 263.6 109.9 57.9 29.9 78.2 68.4 41.1 53.1 4.0 4.1
EQUITY
Common Stock 2.1 1.9 1.4 1.3 1.3 0.9 0.9 0.9 0.7 0.7 3.41 K 1.52 K 1.57 K
Retained Earnings (1 094.0) (1 023.2) (909.3) (743.8) (585.8) (455.7) (318.5) (231.6) (161.5) (47.2) (32.3) (17.6) (9.7)
Other Accumulative Comprehensive Income/Loss (1.9) (3.7) (0.9) (11.1) (10.0) (7.3) (9.8) (21.6) (14.2) 126.7 0.2 47.1 K 7.85 K
Total Equity 11.8 39.5 81.9 206.0 341.2 123.6 246.9 203.0 166.1 259.6 2.4 (2.2) (0.1)
Total Liabilities and Equity 246.0 282.6 328.9 469.5 451.1 181.5 276.7 281.1 234.5 300.7 55.5 1.8 4.0
SHARES OUTSTANDING
Common Shares Outstanding 1 513.8 1 206.4 967.2 934.8 854.8 629.8 584.3 527.6 424.7 214.7 304.3 101.2